Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®
February 6, 2023Business Services
Basel, February 4, 2023 – Novartis announced today that The Lancet has published long-term data from the pivotal SUNSHINE and …
SPR Therapeutics gains FDA extended approval for pain management system
February 6, 2023Research and Development
Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System …
Australia’s TGA approves psychedelics to treat mental health conditions
February 6, 2023Research and Development
Australia’s Therapeutic Goods Administration (TGA) has announced its approval of the use of psychedelics to treat certain mental health conditions. …
Daiichi Sankyo to build Japan’s first factory for mRNA COVID-19 vaccines
February 6, 2023Manufacturing and Production
Daiichi Sankyo have announced its plans to build Japan’s first factory for mRNA COVID-19 vaccines. The new facility is expected …
Boston Scientific fined $42m over patent infringement
February 6, 2023Medical Communications
A five-year legal battle between Boston Scientific and TissueGen has culminated in a $42m fine, which Boston Scientific must pay …
Businesses from the UK are in the top four foreign investors in Flanders in 2022
February 3, 2023Business Services
Investment figures released this week by Flanders Investment & Trade show that UK businesses are continuing to make significant investments …
IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER
February 3, 2023Business Services
London, UK, Thursday 2 February 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …
MHRA Approves RINVOQ®▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn’s Disease
February 3, 2023Business Services
MAIDENHEAD, UK, 01 February 2023 – AbbVie (NYSE: ABBV) today announced that the UK Medicines and Healthcare products Regulatory Agency …
Phlo raises £10m to spearhead digital transformation in pharmacy sector
February 3, 2023Business Services
[Glasgow, Scotland] Phlo, UK digital pharmacy leaders, have closed a £10m Series A round led by family office Thairm Bio. …
Drug-resistant bacteria found in eye drops has infected 55 people in 12 states
February 3, 2023Medical Communications
A strongly drug-resistant bacteria has been found in multiple brands of artificial tears eyedrops; the most commonly reported was EzriCare …
DrugBAN AI expected to reduce costs and speed up drug discovery
February 3, 2023Medical Communications
In a collaboration between Sheffield University and pharma giant, AstraZeneca, a new AI has been developed which could help deliver …
Genoscience Pharma received Orphan Drug Designation for hepatocellular carcinoma drug
February 3, 2023Medical Communications
French clinical-stage biotech company Genoscience has received FDA Orphan Drug Designation (ODD) for its lead candidate ezurpimtrostat. OOD qualifies the …
Insilico Medicine opens new R&D facility in Abu Dhabi
February 3, 2023Research and Development
Hong Kong-based healthtech company Insilico Medicine recently opened its eighth global laboratory in Abu Dhabi. Utilising Abu Dhabi’s Masdar …
Novartis announces cut to multiple drug research programmes in 2022 full-year report
February 2, 2023Business Services
Novartis, a Swiss pharmaceutical company, has announced in its 2022 full-year report that it is cutting several of their programmes, …
Sherlock Biosciences acquires Sense Biodetection to advance CRISPR-based diagnostics
February 2, 2023Business Services
US-based biotech company Sherlock Biosciences has acquired UK-based developer of rapid molecular diagnostics Sense Biodetection. The acquisition will integrate …
Tadashi Maruno
February 2, 2023Sales and Marketing
Hamamatsu Photonics Announces Mr. Tadashi Maruno as Representative Director and PresidentHamamatsu Photonics, a leading provider of cutting-edge photonics technology, …
Joydeep Goswami
February 2, 2023Sales and Marketing
Illumina Appoints Joydeep Goswami Chief Financial Officer
PureTech to Present at the SVB Securities Global Biopharma Conference
February 1, 2023Business Services
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …
Ellipses Pharma announces FDA approval of IND application for EP0042 for patients with acute myeloid leukaemia
February 1, 2023Business Services
Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …
ViCentra bolsters leadership team with the appointment of Leo Toole as Chief Financial Officer and expands European commercialization
February 1, 2023Business Services
February 1, Utrecht, The Netherlands ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest and most …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
